Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
12
NCT01319331
The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes
Phase: Phase 1
Role: Collaborator
Start: Oct 31, 2010
Completion: May 31, 2016